| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |